TY3S:XETRA:XETRA-WisdomTree US Treasuries 10Y 3x Daily Short (EUR)

COMMON STOCK | Others |

Last Closing

USD 105.87

Change

-0.70 (-0.66)%

Market Cap

N/A

Volume

247.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
USUP:XETRA UBS(Lux)Fund Solutions – MSC..

-0.02 (-0.22%)

USD 1.07B
WEBH:XETRA Amundi MSCI USA UCITS ETF Acc ..

-0.48 (-1.25%)

USD 0.86B
CA1:XETRA Circus SE

-0.80 (-3.96%)

USD 0.51B
7V0:XETRA Darwin AG

+1.00 (+3.52%)

USD 0.08B
8PSB:XETRA Invesco Physical Markets PLC O

+0.16 (+0.53%)

N/A
ABCH:XETRA 21Shares Bitcoin Cash ETP

-0.12 (-0.91%)

N/A
42FB:XETRA AI/ML Innovations Inc.

-0.01 (-10.00%)

N/A
2BTD:XETRA 2BTD

+0.43 (+1.32%)

N/A
AXTZ:XETRA 21Shares Tezos staking ETP

+0.02 (+0.45%)

N/A
BRNK:XETRA BRANICKS Group AG

+0.01 (+0.22%)

N/A

ETFs Containing TY3S:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.31% 35% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.31% 35% F 26% F
Trailing 12 Months  
Capital Gain 10.13% 42% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.13% 42% F 56% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 20.86% 61% D- 79% B-
Dividend Return 20.86% 61% D- 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 22.46% 61% D- 70% C-
Risk Adjusted Return 92.88% 89% A- 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike